Compare MNKD & TALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNKD | TALO |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2004 | N/A |
| Metric | MNKD | TALO |
|---|---|---|
| Price | $5.95 | $11.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $10.08 | ★ $14.30 |
| AVG Volume (30 Days) | ★ 3.5M | 1.6M |
| Earning Date | 02-25-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.47 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | $313,787,000.00 | ★ $1,872,554,000.00 |
| Revenue This Year | $21.40 | N/A |
| Revenue Next Year | $25.03 | N/A |
| P/E Ratio | $58.33 | ★ N/A |
| Revenue Growth | ★ 17.43 | 0.06 |
| 52 Week Low | $3.38 | $6.23 |
| 52 Week High | $6.51 | $12.32 |
| Indicator | MNKD | TALO |
|---|---|---|
| Relative Strength Index (RSI) | 57.73 | 49.47 |
| Support Level | $5.03 | $11.05 |
| Resistance Level | $5.68 | $11.77 |
| Average True Range (ATR) | 0.27 | 0.47 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 61.15 | 39.04 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.